Agmatine

An arginine-derived molecule, not a peptide. The body and gut bacteria make agmatine. Supplements usually contain its sulfate salt as powder or capsules. Arginine and citrulline are different substances; their gram amounts are not interchangeable.

Agmatine sulfate is an oral supplement discussed for workout pumps, calmer thinking, renewed enjoyment and nerve pain. The same compound has two very different audiences: lifters and nootropic experimenters. Reports range from useful calm to no change, stomach trouble or emotional flattening.

Fuller muscles during training. Pumps and visible veins are reported, alongside nonresponse. Pumps do not demonstrate muscle growth. My Experience with Agmatine (Community discussion · Accessed 2026-09-30) · Agmatine trouble (Community discussion · Accessed 2026-09-30)

Less anxiety or more enjoyment. Less rumination and renewed sociability coexist with fog, apathy and nonresponse. Calm, energy and enjoyment can change separately. Agmatine cures my anxiety for 3 hours (Community discussion · Accessed 2026-09-30) · Agmatine, an unlikely candidate, has cured my anhedonia after over a month of use (Community discussion · Accessed 2026-09-30) · Agmatine and dopamine (Community discussion · Accessed 2026-09-30) · My Experience with Agmatine (Community discussion · Accessed 2026-09-30)

Less nerve pain or different stimulant effects. Pain logs and tolerance experiments explain daily use. A reduced stimulant buzz does not establish restored sensitivity or adequate pain treatment. Agmatine is the WORST noot I tried EVER. (Community discussion · Accessed 2026-09-30) · My Experience with Agmatine (Community discussion · Accessed 2026-09-30)

Source context — My Experience with Agmatine: Unverified products, self-reports, injury and co-use; OP's pain improvement and adverse response are one person's trajectory. No diagnosis, controlled comparison or prevalence inference.

Source context — Agmatine trouble: OP contains an apparent '500g' typo; not transcribed as a real amount. First-person course includes blend/caffeine confounding. Representative's glucose/BP explanations lack measurements; no confirmed hypoglycemia or BP threshold. Repeated quote blocks are one story.

Source context — Agmatine cures my anxiety for 3 hours: Title is the author's claim, not an accepted cure. Oral-use context; exact products not verified. Advice for frequent dosing, blanket safety, diagnoses and medication substitutions rejected.

Source context — Agmatine, an unlikely candidate, has cured my anhedonia after over a month of use: Self-described anhedonia with depression, stimulant and antidepressant history. Mechanistic interpretation and cure title are not established facts; skipped-dose/benzodiazepine confounding retained. No measured persistence after discontinuation.

Source context — Agmatine and dopamine: Alcohol, SSRI/pregabalin history and unverified product complicate attribution. OP inferred glutamate from symptoms; no measurement supports it. Improvement and later severe symptoms remain one account. Another commenter's two-month recovery is a different account, not the OP's recovery.

Source context — Agmatine is the WORST noot I tried EVER.: OP lists 250–4000 mg acute experiments, not a verified dose-response study. Same author supplies negative and rebound phases. Other substances/genetic theories do not identify a mechanism; favorable replies do not establish frequency.

Workout notes: 500–1000 mg per use. One lifter reports 500 mg before training three times/week. A commercially influenced forum separately includes 1000–1500 mg per workout use. My Experience with Agmatine (Community discussion · Accessed 2026-09-30) · Agmatine for a good pump? All day? (Community discussion · Accessed 2026-09-30)

Nootropic notes: 250–500 mg per use; separate 1 g/day reports. Lower amounts appear in intermittent tolerance talk. A favorable account used 1 g/day; another used 500 mg morning plus evening and felt worse by day five. Agmatine, an unlikely candidate, has cured my anhedonia after over a month of use (Community discussion · Accessed 2026-09-30) · Agmatine and dopamine (Community discussion · Accessed 2026-09-30)

Pain-trial amounts are clinical context. Lumbar-disc nerve-pain cohorts used 1.335, 2.670 or 3.560 g/day for 10–21 days; controlled participants used 2.670 g/day for 14 days. Pain improved more with agmatine, with substantial analysis attrition; highest-dose participants reported diarrhea/nausea. Old ~1.5–2.7 g/day split pain talk borrows formal origins, not cognitive testing. Keynan et al.: Safety and Efficacy of Dietary Agmatine Sulfate in Lumbar Disc-associated Radiculopathy (Official context · Accessed 2026-09-30)

Higher daily grams differ. Pain discussions borrow formal amounts, detailed below. One commenter reported roughly 3 g/day for weeks: no mood/tolerance benefit and diarrhea, rather than a useful target. My Experience with Agmatine (Community discussion · Accessed 2026-09-30)

Source context — My Experience with Agmatine: Unverified products, self-reports, injury and co-use; OP's pain improvement and adverse response are one person's trajectory. No diagnosis, controlled comparison or prevalence inference.

Source context — Agmatine for a good pump? All day?: Commercially influenced forum with multiple representatives and product endorsements, visible signatures. Quantities/timing are reported practice, not effectiveness measurements. No sourcing, discount codes or stacking assurances adopted.

Source context — Agmatine, an unlikely candidate, has cured my anhedonia after over a month of use: Self-described anhedonia with depression, stimulant and antidepressant history. Mechanistic interpretation and cure title are not established facts; skipped-dose/benzodiazepine confounding retained. No measured persistence after discontinuation.

Source context — Agmatine and dopamine: Alcohol, SSRI/pregabalin history and unverified product complicate attribution. OP inferred glutamate from symptoms; no measurement supports it. Improvement and later severe symptoms remain one account. Another commenter's two-month recovery is a different account, not the OP's recovery.

Source context — Keynan et al.: Safety and Efficacy of Dietary Agmatine Sulfate in Lumbar Disc-associated Radiculopathy: Abstract only, not complete methods; 51/48 enrolled versus 31/30 analyzed merits caution. Wiley page showed identity/author commercial affiliations but follow-up abstract lookup errored. Target population is lumbar-disc-related radiculopathy, not healthy mood/workout users. No safety assurance from limited sample; pregnancy/nursing and broad interaction screening not resolved by abstract.

Workout timing: 20–30 minutes beforehand in old notes. This is scheduling, not measured onset. A forum contributor uses 45–60 minutes beforehand; neither establishes optimal absorption. Agmatine for a good pump? All day? (Community discussion · Accessed 2026-09-30)

Anxiety and mood can begin differently. One anxiety poster gives about 20 minutes. A daily-use account noticed renewed emotions in week two; old nootropic notes include subtle effects or nothing in days 1–14. Agmatine cures my anxiety for 3 hours (Community discussion · Accessed 2026-09-30) · Agmatine, an unlikely candidate, has cured my anhedonia after over a month of use (Community discussion · Accessed 2026-09-30)

One anxiety account: about three hours of calm. Anxiety approached panic afterward, before a second 1 g use. Another contributor found single 500 mg capsules patchy. Neither supports three-hourly dosing. Agmatine cures my anxiety for 3 hours (Community discussion · Accessed 2026-09-30)

One flattening account: ten hours, then improvement near 24 hours. The same author reported better mood next day, with possible lingering stimulant blunting. These are phases of one account, not a universal rebound pattern. Agmatine is the WORST noot I tried EVER. (Community discussion · Accessed 2026-09-30)

An all-day pump is disputed. Some users describe prolonged muscle fullness, while others deny an all-day pump. Another lifter reported mood benefits on off days. A perceived mood effect is a different outcome from muscle fullness; neither establishes a shared duration. Agmatine for a good pump? All day? (Community discussion · Accessed 2026-09-30) · My Experience with Agmatine (Community discussion · Accessed 2026-09-30)

No verified human supplement clock here. Old 'hours' shorthand is unmeasured. The two-hour figure originates in a paper, qualified below. Felt relief cannot establish bodily half-life or a repeat-dose interval.

The two-person report and two-hour claim. Commercially involved authors used oral sulfate, 2.67 g/day split morning/evening after meals, for 4–5 years. They reported stable health measures with pre-existing thyroid and cholesterol issues. Their introductory two-hour claim cites urine testing; its accessible abstract does not establish measured blood half-life. Gilad and Gilad: Long-Term (5 Years), High Daily Dosage of Dietary Agmatine—Evidence of Safety: A Case Report (Official context · Accessed 2026-09-30) · Huisman et al.: Novel ELISAs using whole urine samples (Official context · Accessed 2026-09-30)

Rat half-lives remain rat measurements. The 2023 study reports 14.9–18.9 minutes in rat blood after intravenous delivery and 74.4–117 minutes after oral delivery. Longer persistence in brain or spinal tissue is a separate endpoint, not a human effect window. Clements et al.: Biodistribution of Agmatine to Brain and Spinal Cord after Systemic Delivery (Animal context · Accessed 2026-09-30)

Source context — Agmatine for a good pump? All day?: Commercially influenced forum with multiple representatives and product endorsements, visible signatures. Quantities/timing are reported practice, not effectiveness measurements. No sourcing, discount codes or stacking assurances adopted.

Source context — Agmatine cures my anxiety for 3 hours: Title is the author's claim, not an accepted cure. Oral-use context; exact products not verified. Advice for frequent dosing, blanket safety, diagnoses and medication substitutions rejected.

Source context — Agmatine, an unlikely candidate, has cured my anhedonia after over a month of use: Self-described anhedonia with depression, stimulant and antidepressant history. Mechanistic interpretation and cure title are not established facts; skipped-dose/benzodiazepine confounding retained. No measured persistence after discontinuation.

Source context — Agmatine is the WORST noot I tried EVER.: OP lists 250–4000 mg acute experiments, not a verified dose-response study. Same author supplies negative and rebound phases. Other substances/genetic theories do not identify a mechanism; favorable replies do not establish frequency.

Source context — My Experience with Agmatine: Unverified products, self-reports, injury and co-use; OP's pain improvement and adverse response are one person's trajectory. No diagnosis, controlled comparison or prevalence inference.

Source context — Gilad and Gilad: Long-Term (5 Years), High Daily Dosage of Dietary Agmatine—Evidence of Safety: A Case Report: Primary two-author self-case report, commercially conflicted. Mirror is not independent evidence. No blood concentration curve generated by this case; its two-hour introductory assertion cites a urinary-assay paper. Tables retain exceptions despite broad reassuring abstract language. Exact issue day not independently established; publication date denotes issue month.

Source context — Huisman et al.: Novel ELISAs using whole urine samples: Abstract inspected through API; PubMed open yielded no body and ACS full text returned 403. Urinary excretion is different from parent-drug blood elimination. Cannot certify or disprove the full paper's blood estimate from the abstract alone; exact issue day not independently established.

Source context — Clements et al.: Biodistribution of Agmatine to Brain and Spinal Cord after Systemic Delivery: Primary abstract inspected through API; PubMed/PMC body attempts gave browser-check pages and Europe PMC fullTextXML returned HTTP 500. Search-index table was a lead only, not full methods acceptance. Rat route-specific data cannot become a human clock.

Lift days, four evenings/week and daily use differ. The old tolerance pattern has no measured benefit or agreed break length. Daily mood/pain use differs from workout pulses; no standard six-week cycle emerges. My Experience with Agmatine (Community discussion · Accessed 2026-09-30)

Stopping stories disagree. Old notes describe fading without classic withdrawal. The favorable month-long author reported partial symptom return on missed days with benzodiazepine use. An adverse account's fog eased four days off, but further panic and detachment were reported. Agmatine, an unlikely candidate, has cured my anhedonia after over a month of use (Community discussion · Accessed 2026-09-30) · Agmatine and dopamine (Community discussion · Accessed 2026-09-30)

Source context — My Experience with Agmatine: Unverified products, self-reports, injury and co-use; OP's pain improvement and adverse response are one person's trajectory. No diagnosis, controlled comparison or prevalence inference.

Source context — Agmatine, an unlikely candidate, has cured my anhedonia after over a month of use: Self-described anhedonia with depression, stimulant and antidepressant history. Mechanistic interpretation and cure title are not established facts; skipped-dose/benzodiazepine confounding retained. No measured persistence after discontinuation.

Source context — Agmatine and dopamine: Alcohol, SSRI/pregabalin history and unverified product complicate attribution. OP inferred glutamate from symptoms; no measurement supports it. Improvement and later severe symptoms remain one account. Another commenter's two-month recovery is a different account, not the OP's recovery.

Citrulline: It appears in workout combinations alongside concerns about lightheadedness or blood pressure. The accounts do not quantify an interaction or establish safety. [community]

Caffeine: Reports include perceived enhancement and blunting, without a dependable prediction of either response. [community]

Stimulant blunting differs from tolerance repair. Old notes describe noticing blunting within the same week, alongside caffeine synergy claims. The ten-hour author felt coffee and methylphenidate blocked; another commenter reported no anhedonia up to 600 mg/day. Neither predicts who benefits. Agmatine is the WORST noot I tried EVER. (Community discussion · Accessed 2026-09-30)

PEA: Pain discussion pairs agmatine with palmitoylethanolamide, the lipid. Different proposed mechanisms do not establish a shared time course or a useful combination. [community]

Comparisons do not mean equivalence. Older pain discussion compares agmatine with PEA, meaning palmitoylethanolamide, and describes changes over weeks or months. That does not establish equivalent effects or a common time course. Arginine-related herpes claims are not agmatine evidence, and citrulline combinations do not establish compatibility.

Source context — Agmatine is the WORST noot I tried EVER.: OP lists 250–4000 mg acute experiments, not a verified dose-response study. Same author supplies negative and rebound phases. Other substances/genetic theories do not identify a mechanism; favorable replies do not establish frequency.

Gut trouble, fog and palpitations appear. Reports include nausea, diarrhea, headaches and tiredness. The lifter who liked 500 mg described fog and palpitations with two 500 mg portions; lower amounts were not universally symptom-free. My Experience with Agmatine (Community discussion · Accessed 2026-09-30)

Calm can become unwanted flattening. Poor enjoyment, motivation and sleep, or feeling detached, are reported. Severe mental changes and faintness are not evidence of beneficial tolerance repair. Agmatine is the WORST noot I tried EVER. (Community discussion · Accessed 2026-09-30) · Agmatine and dopamine (Community discussion · Accessed 2026-09-30) · My Experience with Agmatine (Community discussion · Accessed 2026-09-30)

Stopping stories disagree. Old notes describe fading without classic withdrawal. The favorable month-long author reported partial symptom return on missed days with benzodiazepine use. An adverse account's fog eased four days off, but further panic and detachment were reported. Agmatine, an unlikely candidate, has cured my anhedonia after over a month of use (Community discussion · Accessed 2026-09-30) · Agmatine and dopamine (Community discussion · Accessed 2026-09-30)

Stacks complicate attribution. Old cautions name lightheadedness and blood-pressure drops with pump substances or tadalafil. Caffeine, medicines and overlapping blends complicate causality; stacks do not establish compatibility. Agmatine trouble (Community discussion · Accessed 2026-09-30)

Source context — My Experience with Agmatine: Unverified products, self-reports, injury and co-use; OP's pain improvement and adverse response are one person's trajectory. No diagnosis, controlled comparison or prevalence inference.

Source context — Agmatine is the WORST noot I tried EVER.: OP lists 250–4000 mg acute experiments, not a verified dose-response study. Same author supplies negative and rebound phases. Other substances/genetic theories do not identify a mechanism; favorable replies do not establish frequency.

Source context — Agmatine and dopamine: Alcohol, SSRI/pregabalin history and unverified product complicate attribution. OP inferred glutamate from symptoms; no measurement supports it. Improvement and later severe symptoms remain one account. Another commenter's two-month recovery is a different account, not the OP's recovery.

Source context — Agmatine, an unlikely candidate, has cured my anhedonia after over a month of use: Self-described anhedonia with depression, stimulant and antidepressant history. Mechanistic interpretation and cure title are not established facts; skipped-dose/benzodiazepine confounding retained. No measured persistence after discontinuation.

Source context — Agmatine trouble: OP contains an apparent '500g' typo; not transcribed as a real amount. First-person course includes blend/caffeine confounding. Representative's glucose/BP explanations lack measurements; no confirmed hypoglycemia or BP threshold. Repeated quote blocks are one story.